Press Release with the title Morepen Labs adds three new drugs - Rivaroxaban Vildagliptin and UDCA to its API portfolio.
14-Oct-2019
Download PDF
Morepen Lab
Press Release with the title Morepen Labs adds three new drugs - Rivaroxaban Vildagliptin and UDCA to its API portfolio.